SVRE (SVRE) Stock Price & Analysis
SVRE (SVRE) fell 7.61% to USD 3.95 as of June 10, 2026 at 00:26 UTC, according to Nexqual real-time market data.
SVRE last closed at USD 4.27; the session ranged USD 3.75–4.3 on volume of 19,725 shares. Market capitalization is $3.69M, with a 52-week range of USD 2.2–68.28 (NCM). Source: Nexqual, June 10, 2026 at 00:26 UTC.
Key Statistics (as of June 10, 2026 at 00:26 UTC)
| Price | USD 3.95 |
|---|---|
| Change | ▼ 7.61% (down) |
| Previous Close | USD 4.27 |
| Open | USD 4.3 |
| Day Range | USD 3.75 – 4.3 |
| 52-Week Range | USD 2.2 – 68.28 |
| Volume | 19,725 shares |
| Market Cap | $3.69M |
| Exchange | NCM |
Technical Analysis (SVRE)
Nexqual's technical model rates SVRE "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:26 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.97 (neutral) |
| vs SMA50 | Below (USD 4.26) |
| MACD | -0.11 (negative) |
Analyst Ratings (SVRE)
Wall Street analysts rate SVRE "None", per Nexqual as of June 10, 2026 at 00:26 UTC.
| Consensus Rating | None |
|---|
Earnings (SVRE)
Source: Nexqual, June 10, 2026 at 00:26 UTC.
Financials & Fundamentals (SVRE)
| Revenue Growth (YoY) | -78.30% |
|---|---|
| Gross Margin | -143.90% |
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -257.45% |
| Debt / Equity | 42.12 |
| Current Ratio | 2.34 |
| Free Cash Flow | $-17.66M |
Source: Nexqual, June 10, 2026 at 00:26 UTC.
Financial Health Score (SVRE)
Nexqual rates SVRE's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:26 UTC.
| Growth | Critical — Revenue -38% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — Debt/Equity 0.4x |
| Cash Flow | Weak — FCF negative: -$18M, burning cash |
| Efficiency | Critical — ROE -257%, ROA -85.9% |
Ownership (SVRE)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +7.53% |
| Shares Outstanding | 934,241 |
| Float | 28,512 |
| Short % of Float | +0.68% |
Source: Nexqual, June 10, 2026 at 00:26 UTC.
Leadership (SVRE)
SVRE is led by Ori Gilboa (age 61), CEO & Director, per Nexqual as of June 10, 2026 at 00:26 UTC.
| CEO & Director | Ori Gilboa (age 61) |
|---|---|
| Founder & COO | Yossi Cohen (age 58) |
| Chief Financial Officer | Meital Nevo (age 43) |
Major Backers & Investors (SVRE)
Notable institutional backers of SVRE include Rhumbline Advisers, Smartharvest Portfolios, LLC, according to Nexqual as of June 10, 2026 at 00:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Rhumbline Advisers | 6.33% |
| Smartharvest Portfolios, LLC | 1.2% |
Source: Nexqual, June 10, 2026 at 00:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 9.31 | ▼ 18.62% |
| FRGT | Freight Technologies, Inc. | USD 4.5 | ▲ 6.64% |
| ILAG | Intelligent Living Application | USD 3.73 | ▲ 6.57% |
| BBLG | Bone Biologics Corp | USD 1.23 | ▼ 1.52% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.17 | ▼ 12.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:26 UTC. This page is informational and not investment advice.